Hem#265 Rar May 2026

Are you looking to focus on the of RAR or the technical design of the chimera?

Nuclear receptors, such as the Retinoic Acid Receptor (RAR), are critical in gene regulation but often difficult to monitor in real-time within living cells. This paper explores the development of a GR-RAR chimeric protein, which fuses the nuclear/cytoplasmic translocation properties of the Glucocorticoid Receptor (GR) with the ligand responsiveness of RAR. This chimeric receptor provides a robust, in vivo, real-time translocation assay to detect physiological concentrations of RAR ligands, providing a powerful tool for ligand identification and subcellular trafficking analysis. 1. Introduction Hem#265 rar

This paper highlights a novel method that combines the ligand-binding domain (LBD) of RAR with the trafficking machinery of the GR, creating a chimeric receptor that moves from the cytoplasm to the nucleus upon ligand binding. 2. Methodology: Design of the GR-RAR Chimera Are you looking to focus on the of

Do you need me to expand on the (such as specific cell lines used)? This chimeric receptor provides a robust, in vivo,

The chimeric receptor is designed to remain in the cytoplasm of untreated cells.